Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D002369:Castration; D002986:Clinical Trials as Topic; D004247:DNA / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D004054:Diethylstilbestrol / Q000494:pharmacology / Q000627:therapeutic use; D004961:Estramustine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D011467:Prostate / Q000187:drug effects / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy; D029584:Prostatic Secretory Proteins; D051381:Rats; D013997:Time Factors; D014018:Tissue Distribution
D002352:Carrier Proteins; D009588:Nitrogen Mustard Compounds; D029584:Prostatic Secretory Proteins; C028321:estramustine-binding protein; D004961:Estramustine; D004054:Diethylstilbestrol; D004247:DNA